[go: up one dir, main page]

TW200740471A - Asymmetrically coated tablet - Google Patents

Asymmetrically coated tablet

Info

Publication number
TW200740471A
TW200740471A TW095124301A TW95124301A TW200740471A TW 200740471 A TW200740471 A TW 200740471A TW 095124301 A TW095124301 A TW 095124301A TW 95124301 A TW95124301 A TW 95124301A TW 200740471 A TW200740471 A TW 200740471A
Authority
TW
Taiwan
Prior art keywords
tablet
release
core
coating
dissolution
Prior art date
Application number
TW095124301A
Other languages
English (en)
Inventor
Cherng-Ju Kim
Original Assignee
Univ Arkansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arkansas filed Critical Univ Arkansas
Publication of TW200740471A publication Critical patent/TW200740471A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW095124301A 2005-07-08 2006-07-04 Asymmetrically coated tablet TW200740471A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69774305P 2005-07-08 2005-07-08

Publications (1)

Publication Number Publication Date
TW200740471A true TW200740471A (en) 2007-11-01

Family

ID=37637460

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095124301A TW200740471A (en) 2005-07-08 2006-07-04 Asymmetrically coated tablet

Country Status (4)

Country Link
US (1) US10071060B2 (zh)
EP (1) EP1912629A4 (zh)
TW (1) TW200740471A (zh)
WO (1) WO2007008305A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009268934A1 (en) * 2008-06-16 2010-01-14 Appian Labs, Llc Composition and method of preparation of release systems for constant (zero-order) release of active agents
US8580067B2 (en) * 2012-02-23 2013-11-12 Chroma Paper, Llc. Thermo-sealing control method and packaging for resealable packaging
TWI883162B (zh) * 2020-03-31 2025-05-11 大陸商江蘇恆瑞醫藥股份有限公司 一種非布司他片

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2714084A (en) 1954-10-11 1955-07-26 Victor M Hermelin Enteric coated tablets and methods of making the same
US2993837A (en) 1959-07-13 1961-07-25 Frosst & Co Charles E Enteric coated tablets
FR2100858B1 (zh) * 1970-07-03 1975-06-06 Daiichi Seiyaku Co
US4361545A (en) * 1979-05-21 1982-11-30 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4775536A (en) * 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
US4816262A (en) 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
DK469989D0 (da) 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
US5162117A (en) * 1991-11-22 1992-11-10 Schering Corporation Controlled release flutamide composition
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
NZ283160A (en) * 1994-05-06 1998-07-28 Pfizer Azithromycin in a controlled release dosage form for treating microbiol infections
MX9600857A (es) * 1994-07-08 1997-06-28 Astra Ab Forma de dosificacion i en tabletas, con unidades multiples.
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
FI98343C (fi) * 1995-03-21 1997-06-10 Orion Yhtymae Oy Peroraalinen formulaatio
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
IT1282576B1 (it) 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
CN1296417A (zh) * 1998-02-10 2001-05-23 卫福有限公司 控释制剂
US6110500A (en) 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
DE60212475T2 (de) * 2001-03-14 2007-07-05 Pfizer Products Inc., Groton Pharmazeutische Tablette und ein Verfahren zu ihrer Herstellung
US20050025829A1 (en) * 2003-07-29 2005-02-03 Kim Cherng-Ju Controlled drug release tablets
US7713549B2 (en) * 2006-06-30 2010-05-11 Board Of Trustees Of The University Of Arkansas Extended release perforated tablet

Also Published As

Publication number Publication date
EP1912629A4 (en) 2012-09-12
WO2007008305A1 (en) 2007-01-18
EP1912629A1 (en) 2008-04-23
US20070009599A1 (en) 2007-01-11
US10071060B2 (en) 2018-09-11

Similar Documents

Publication Publication Date Title
MX350380B (es) Formas de dosificacion solida de liberacion modificada en el orden de cero.
WO2005076987A3 (en) Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
AU2007247480A8 (en) Pharmaceutical combination comprising 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and an NSAID
EP1804717A4 (en) DRUG DELIVERY COATING FOR USE WITH ONE STENT
MX2009004017A (es) Usos de los compuestos carboxi-amido triazol y sus sales.
UA93903C2 (ru) Производные тетрагидроизохинолина для повышения функции памяти
WO2009091576A3 (en) Parenteral formulations of dopamine agonists
NO20061840L (no) Legemiddelbelegg som tilveiebringer hoy legemiddeltilsetning og fremgangsmater for a tilveiebringe samme
BRPI0817275A2 (pt) Combinação farmacêutica de alisquireno e valsartana
WO2009057138A3 (en) Controlled release pharmaceutical compositions of tolterodine
CL2008003006A1 (es) Uso de ester metilico del acido (-)-(3ar,4s,7ar)-4-hidroxi-4-m-toliletinil-octahidro-indol-1-carboxilico en base libre o en forma de sal para el tratamiento, prevencion o retraso de la progresion de la disquinesia de parkinson asociada a l-dopa; uso de la composicion farmaceutica; uso de una composicion que ademas comprende l-dopa.
WO2008003050A3 (en) Gallium nitrate formulations
WO2007109288A3 (en) Enantiomerically pure r-etifoxine, pharmaceutical compositions thereof and methods of their use
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
TW200740471A (en) Asymmetrically coated tablet
IL193172A0 (en) Phthalazinone pyrazole derivatives, their manufacture and use as pharmaceutical agents
TW200628458A (en) Metasubstituted thiazolidinones, their manufacture and use as a drug
WO2005107467A3 (en) Compositions including opioids and methods of their use in treating pain
JO3239B1 (ar) تركيبات جالينية من مركبات عضوية
BRPI0817563A2 (pt) Composições farmacêuticas que compreendem a combinação de um agente antiinflamatório não esteróide e um agente inibidor da xantino oxidase úteis para o controle e tratamento da gota, artrite gotosas e enfermidades relacionadas
WO2008068778A8 (en) Extended release pharmaceutical composition of pramipexole
PL377706A1 (pl) Kompozycja farmaceutyczna zawierająca kwas alendronowy, jego sole lub estry oraz sposób jej otrzymywania
WO2005120518A3 (en) Use of atp analogues for treatment of cardiovascular diseases
FR2886852B1 (fr) Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee
WO2007086911A3 (en) Stable nanoparticle formulations